References
- Brimblecombe R. W., Duncan W. A.M., Durant G. J., Emmett J. C., Ganellin C. R., Parsons M. E. J. Int. Med. Res. 1975; 3: 86
- Newton J. M. Pharm. Weekblad 1972; 107: 485
- British Pharmacopoeia. Her Majesty's Stationery Office, London 1973; Al31, Appendix XIXA
- United States Pharmacopoeia. The USP Convention, Inc. 1975; 651
- Declaration of Helsinki, Adopted by 18th World Medical Assembly, Helsinki, Finland. World Med. J. 1964; 11(5)281
- Randolph W. C., Osborne V. L., Walkenstein S. S., Intoccia A. P. J. Pharm. Sci. 1977; 66(8)1148
- Berry H., Ridout C. W. J. Pharm. Pharmacol. 1950; 2: 619
- Griffiths R., Lee R. M., Taylor D. C. (1977) Excerpta Medica. Proceedings of the Second International Symposium on Histamine H2-Receptor Antagonists. 1977, W. L. Burland, M. A. Simkins. Oxford, 38
- Henn R. M., Isenberg J. I., Maxwell V., Studevant R. A.L. New Engl. J. Med. 1975; 293: 371